← Open Payments lookup

BRAD GINEVAN: Open Payments

NPI 1285732016 · SHEFFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,635 in 113 payments from 21 companies in 2025. Trend: 2023 $2,661 · 2024 $2,588 · 2025 $1,635

Food & beverage: $1,635
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP18$352
Salix Pharmaceuticals, a division of Bausch Health US, LLC21$255
ABBVIE INC.29$218
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$136
Axsome Therapeutics, Inc.7$129
PFIZER INC.5$76
Novo Nordisk Inc4$66
Phathom Pharmaceuticals, Inc.4$58
Takeda Pharmaceuticals U.S.A., Inc.3$46
Corcept Therapeutics2$43

Products named: RELISTOR, AIRSUPRA, CAPLYTA, BREZTRI, Auvelity, UBRELVY, QULIPTA, FARXIGA.

Industry payments across AL — which companies pay providers there.